An integrated research organisation, run like one
We own our sites, employ our investigators and answer for our own data. That is a deliberate choice, and it shapes everything else about how we work.
Built by people who had run sites badly first
JustClinicals started in 2016 in a converted GP practice in Milton Keynes, founded by two investigators and a study coordinator who had spent a decade watching good protocols fail for avoidable reasons — sites recruited on optimism, coordinators who left mid-study, source documents that only made sense to the person who wrote them.
The premise was simple: if you own the sites, you can fix those things. You can retain coordinators by paying and training them properly. You can standardise source documentation across every location. You can tell a sponsor honestly, during feasibility, that their recruitment assumption is wrong.
Nine sites and 240 studies later, the premise still holds. We have grown slowly and turned down more work than we have taken, because the moment a network grows faster than its quality system, it stops being a network and becomes a list of addresses.
What has not changed: every site is owned, every investigator is employed, and every study has one person whose name is against it.
Four commitments we are measured on
Participant safety before recruitment targets
If a volunteer is borderline against eligibility criteria, they are not enrolled. Screen failure rates are a cost we accept; enrolling someone who should not be in a study is not.
Honest feasibility, even when it loses us the study
We give sponsors our real recruitment history in the indication, including the studies where we under-delivered. An accurate no is worth more than an optimistic yes.
Data that survives inspection without a scramble
Our documentation is maintained to inspection standard continuously, not reconstructed when a notification arrives. Sponsors can audit any site with two weeks' notice.
Research that reaches beyond the usual volunteers
A trial population that does not resemble the patient population produces evidence of limited use. We invest in community outreach because representative recruitment is a scientific requirement, not a public-relations exercise.
Trust is built before the study opens
People decline clinical research for reasons that are usually rational: they were not asked, they were asked badly, or someone in their community was treated poorly by researchers within living memory. None of that is solved by a recruitment advert.
So we spend time in the places we operate. Open evenings at each site where anyone can walk in and ask what a placebo actually is. Sessions with sixth-form science students. Briefings with faith and community groups, in the languages those groups use.
It is slow, unglamorous work and it does not appear on a study budget line. It is also the reason our registry now broadly reflects the demographics of the cities we work in.
Regulated, inspected, accountable
MHRA & FDA
All UK sites operate under MHRA oversight and all US sites under FDA regulation. Our last inspections closed with no critical findings.
ICH-GCP E6(R3)
Every member of study-facing staff holds current GCP certification, refreshed on a two-year cycle and tracked centrally.
Ethics & IRB
Studies are reviewed by an independent research ethics committee or institutional review board before any participant is approached.
ISO 27001
Information security management certified across our eSource, CTMS and participant registry systems.
GMC approved training
Approved site for the Pharmaceutical Medicine Specialty Training programme for GMC-registered doctors.
UK GDPR & HIPAA
Participant data is handled under UK GDPR in Britain and HIPAA in the United States, with regional data residency.
Thinking about taking part in a study?
Volunteers learn more about their own condition, gain early access to investigational treatments, and move medicine forward for everyone who comes next. Every visit is supervised by a qualified investigator, and you can withdraw at any point.